These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24188890)

  • 1. Meta-analysis of the effect of automated contrast injection devices versus manual injection and contrast volume on risk of contrast-induced nephropathy.
    Minsinger KD; Kassis HM; Block CA; Sidhu M; Brown JR
    Am J Cardiol; 2014 Jan; 113(1):49-53. PubMed ID: 24188890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of automated contrast injector systems on contrast use and contrast-associated complications in patients undergoing percutaneous coronary interventions.
    Gurm HS; Smith D; Share D; Wohns D; Collins J; Madala M; Koneru S; Menees D; Chetcuti S
    JACC Cardiovasc Interv; 2013 Apr; 6(4):399-405. PubMed ID: 23523450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in Contrast Nephropathy From Coronary Angiography and Percutaneous Coronary Intervention With Ultra-Low Contrast Delivery Using an Automated Contrast Injector System.
    Kelly SC; Li S; Stys TP; Thompson PA; Stys AT
    J Invasive Cardiol; 2016 Nov; 28(11):446-450. PubMed ID: 27430665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy.
    Call J; Sacrinty M; Applegate R; Little W; Santos R; Baki T; Gandhi S; Kahl F; Kutcher M
    J Invasive Cardiol; 2006 Oct; 18(10):469-74. PubMed ID: 17042103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease.
    Demir OM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A; Azzalini L
    Am J Cardiol; 2018 Dec; 122(11):1837-1842. PubMed ID: 30292337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the use of traditional hand injection versus automated contrast injectors during cardiac catheterization.
    Godley RW; Joshi K; Breall JA
    J Invasive Cardiol; 2012 Dec; 24(12):628-30. PubMed ID: 23220975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F; Yarlioglues M; Cay S; Celik IE; Mendi MA; Kurtul A; Cankurt T; Kuyumcu S; Canpolat U; Turak O
    Am J Cardiol; 2015 Sep; 116(5):711-6. PubMed ID: 26116992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
    Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of platelets indices in the development of contrast-induced nephropathy.
    Sahin I; Karabulut A; Avci II; Okuyan E; Biter HI; Yildiz SS; Can MM; Gungor B; Dinckal M; Serebruany V
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):246-9. PubMed ID: 24695089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.
    Kanbay M; Siriopol D; Ozdogan E; Afsar B; Ertuglu LA; Grigore M; Sag AA; Kuwabara M; Lanaspa MA; Ortiz A; Johnson RJ; Covic A
    Int Urol Nephrol; 2020 Mar; 52(3):541-547. PubMed ID: 32008199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Liu Y; Hong D; Wang AY; Guo R; Smyth B; Liu J; Sun G; Chen S; Tan N; Jardine M; Brieger D; Shaman A; Islam S; Chen J; Gallagher M
    BMC Cardiovasc Disord; 2019 Apr; 19(1):87. PubMed ID: 30961544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
    Zhang J; Jiang Y; Rui Q; Chen M; Zhang N; Yang H; Zhou Y
    Medicine (Baltimore); 2018 May; 97(18):e0617. PubMed ID: 29718868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote Ischemic Preconditioning Reduces the Risk of Contrast-Induced Nephropathy in Patients with Moderate Renal Impairment Undergoing Percutaneous Coronary Angiography: A Meta-Analysis.
    Deng J; Lu Y; Ou J; Shao X; Wang X; Xie H
    Kidney Blood Press Res; 2020; 45(4):549-564. PubMed ID: 32688358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for contrast-induced nephropathy after coronary angiography.
    Kumar S; Nair RK; Aggarwal N; Abbot AK; Muthukrishnan J; Kumar KV
    Saudi J Kidney Dis Transpl; 2017; 28(2):318-324. PubMed ID: 28352014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast volume use in manual vs automated contrast injection systems for diagnostic coronary angiography and percutaneous coronary interventions.
    Hwang JR; D'Alfonso S; Kostuk WJ; Diamantouros P; Teefy P; Jablonsky G; Lavi S
    Can J Cardiol; 2013 Mar; 29(3):372-6. PubMed ID: 23352426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
    Bagshaw SM; Ghali WA
    Arch Intern Med; 2005 May; 165(10):1087-93. PubMed ID: 15911721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
    Reed PS; Dixon SR; Boura JA; O'Neill WW; Kahn JK
    Am J Cardiol; 2007 Oct; 100(7):1090-3. PubMed ID: 17884368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study).
    Ko YG; Lee BK; Kang WC; Moon JY; Cho YH; Choi SH; Hong MK; Jang Y; Kim JY; Min PK; Kwon HM;
    Yonsei Med J; 2013 Jul; 54(4):957-64. PubMed ID: 23709432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
    Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
    Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.